Methimazole-induced hypothyroidism inhibits the panic-like behaviors produced by electrical stimulation of dorsal periaqueductal gray matter of rats

Psychoneuroendocrinology

Volumn 35, Issue 5, 2010, Pages 706-716

  Siqueira, Carla Coelho ^a   Rossoni, Renzo Roldi ^a   Tiengo, Ana Neide Carleti Pereira ^a   Tufik, Sérgio ^b   Schenberg, Luiz Carlos ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Defensive behaviors; Elevated plus maze; PAG; Panic; Thyroid

Indexed keywords

THIAMAZOLE; THYROTROPIN; THYROXINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DEFECATION; DEFENSIVE BEHAVIOR; ELECTRODE; ELECTROSTIMULATION; EXOPHTHALMOS; EXPLORATORY BEHAVIOR; HYPOTHYROIDISM; IMMOBILIZATION; JUMPING; MALE; MAZE TEST; MICTURITION; MORNING DOSAGE; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION;

ANIMALS; ANXIETY; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; HYPOTHYROIDISM; MALE; MAZE LEARNING; METHIMAZOLE; PANIC DISORDER; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; THYROTROPIN; THYROXINE;

EID: 77952528731     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.10.011     Document Type: Article

References (79)

1. Abel E.D., Ahima R.S., Boers M.E., Elmquist J.K., Wondisford F.E. Critical role for thyroid hormone receptor beta-2 in the regulation of paraventricular thyrotropin-releasing hormone neurons. J. Clin. Invest. 2001, 107:1017-1023.
2. Abel E.D., Moura E.G., Ahima R.S., Campos-Barros A., Pazos-Moura C.C., Boers M.E., Kaulbach H.C., Forrest D., Wondisford F.E. Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone. Mol. Endocrinol. 2003, 17:1767-1776.
3. Beijamini V., Guimaraes F.S. Activation of neurons containing the enzyme nitric oxide synthase following exposure to an elevated plus maze. Brain Res. Bull. 2006, 69:347-355.
4. Bertoglio L.J., de Bortoli V., Zangrossi H. Cholecystokinin-2 receptors modulate freezing and escape behaviors evoked by the electrical stimulation of the rat dorsolateral periaqueductal gray. Brain Res. 2007, 1156:133-138.
5. Bittencourt A.S., Carobrez A.P., Zamprogno L.P., Tufik S., Schenberg L.C. Organization of single components of defensive behaviors within distinct columns of periaqueductal gray matter of the rat, role of N-methyl-d-aspartic acid glutamate receptors. Neuroscience 2004, 125:71-89.
6. Borelli K.G., Ferreira-Netto C., Coimbra N.C., Brandão M.L. Fos-like immunoreactivity in the brain associated with freezing or escape induced by inhibition of either glutamic acid decarboxylase or GABA-A receptors in the dorsal periaqueductal gray. Brain Res. 2005, 1051:100-111.
7. Bunevicius R., Velickiene D., Prange A.J. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease. Gen. Hosp. Psychiatry 2005, 27:133-139.
8. Castellani S., Quillen M.A., Vaughan D.A., Hund M.A., Ho L., Ziegler M.G., Le Vine W.R. TSH and catecholamine response to TRH in panic disorder. Biol. Psychiatry 1988, 24:87-90.
9. Collett D. Modelling Binary Data 2003, Chapman & Hall, London.
10. Corrigan M.H.N., Gillette G.M., Quade D., Garbutt J.C. Panic, suicide, and agitation: independent correlates of the response to TRH in depression. Biol. Psychiatry 1992, 31:984-992.
11. Coupland N., Malizia A., Bailey J., Nutt D. Thyrotropin-releasing hormone: a potential comparator for the panicogenic effects of pentagastrin and CCK?. Biol. Psychiatry 1996, 39:465-466.
12. Darbra S., Garau A., Balada F., Sala J., Marti-Carbonell M.A. Perinatal hypothyroidism effects on neuromotor competence, novelty-directed exploratory and anxiety-related behaviour and learning in rats. Behav. Brain Res. 2003, 143:209-215.
13. Deakin J.F.W., Graeff F.G. 5-HT and mechanisms of defence. J. Psychopharmacol. (Berl.) 1991, 5:305-315.
14. Demet M.M., Ozmen B., Deveci A., Boivada S., Adiguzel H., Aydemir O. Depression and anxiety in hyperthyroidism. Arch. Med. Res. 2002, 33:552-556.
15. Duncan G.E., Knapp D.J., Breese G.R. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res. 1996, 713:79-91.
16. Engum A., Bjoro T., Mykletun A., Dahl A.A. Association between depression, anxiety and thyroid function-a clinical fact or an artifact. Acta Psychiatr. Scand. 2002, 106:27-34.
17. Eskay R.L., Long R.T., Palkovits M. Localization of immunoreactive thyrotropin releasing hormone in the lower brainstem of the rat. Brain Res. 1983, 277:159-162.
18. Fardella C., Gloger S., Figueroa R., Santis R., Gajardo C., Salgado C., Barroilhet S., Foradori A. High prevalence of thyroid abnormalities in a Chilean psychiatric outpatient population. J. Endocrinol. Invest. 2000, 23:102-106.
19. Fekete C., Lechan R.M. Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Front. Neuroendocrinol. 2007, 28:97-114.
20. Fishman S.C., Sheehan M.B., Carr D.B. Thyroid indices in panic disorder. J. Clin. Psychiatry 1985, 46:432-433.
21. Frye M.A., Dunn R.T., Gary K.A., Kimbrell T.A., Callahan A.M., Luckenbaugh D.A., Cora-Locatelli G., Vanderham E., Winokur A., Post R.M. Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression. Biol. Psychiatry 1999, 45:1049-1052.
22. Gillette G.M., Garbut J.C., Quade D.E. TSH Response to TRH in depression with and without panic attacks. Am. J. Psychiatry 1989, 146:743-748.
23. Hayward L.F., Castellanos M. Increased c-Fos expression in select lateral parabrachial subnuclei following chemical versus electrical stimulation of the dorsal periaqueductal gray in rats. Brain Res. 2003, 974:153-166.
24. He C.T., Hsieh A.T., Pei D., Hung Y.J., Wu L.Y., Yang T.C., Lian W.C., Huang W.S., Kuo S.W. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. Clin. Endocrinol. (Oxf.) 2004, 60:676-681.
25. Jenck F., Moreau J.L., Martin J.R. Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Res. 1995, 57:181-191.
26. Kikuchi M., Komuro R., Oka H., Kidani T., Hanaoka A., Koshino Y. Relatioship between anxiety and thyroid function in panic disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:77-81.
27. Klein D.F. Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia (Berl.) 1964, 5:397-408.
28. Koller K.J., Wolff R.S., Warden M.K., Zoeller R.T. Thyroid hormones regulate levels of thyrotropin-releasing-hormone mRNA in the paraventricular nucleus. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:7329-7333.
29. Larisch R., Kley K., Nikolaus S., Sitte W., Franz M., Hautzel H., Tress W., Muller H.W. Depression and anxiety in different thyroid function states. Horm. Metab. Res. 2004, 36:650-653.
30. Larsen P.R., Ingbar S.H. The thyroid gland. Williams Textbook of Endocrinology 2003, 357-487. W.B. Saunders Company, Philadelphia. J.D. Wilson, D.W. Foster (Eds.).
31. Lee I.T., Sheu W.H., Liau Y.J., Lin S.Y., Lee W.J., Lin C.C. Relationship of stressful life events, anxiety and depression to hyperthyroidism in an Asian population. Horm. Res. 2003, 60:247-251.
32. Lesser I.M., Rubin R.T., Lydiard R.B., Swinson R., Pecknold J. Past and current thyroid function in subjects with panic disorder. J. Clin. Psychiatry 1987, 48:473-476.
33. Liao N., Bulant M., Nicolas P., Vaudry H., Pelletier G. Immunocytochemical distribution of neurons containing a peptide derived from thyrotropin-releasing hormone precursor in the rat brain. Neurosci. Lett. 1988, 85:24-28.
34. Loosen P.T., Prange A.J. Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am. J. Psychiatry 1982, 139:405-416.
35. Lovick T.A. Interactions between descending pathways from the dorsal and ventrolateral periaqueductal gray matter in the rat. The Midbrain Periaqueductal Gray Matter 1991, 101-120. Plenum Press, New York. A. Depaulis, R. Bandler (Eds.).
36. Mihaly E., Legradi G., Fekete C., Lechan R.M. Efferent projections of ProTRH neurons in the ventrolateral periaqueductal gray. Brain Res. 2001, 919:185-197.
37. Morgan M.M., Carrive P. Activation of the ventrolateral periaqueductal gray reduces locomotion but not mean arterial pressure in awake, freely moving rats. Neuroscience 2001, 102:905-910.
38. Munjack D.J., Palmer R. Thyroids hormones in panic disorder, panic disorder with agoraphobia, and generalized anxiety disorder. J. Clin. Psychiatry 1988, 49:229-231.
39. Nashold B.S., Wilson W.P., Slaughter D.G. Sensations evoked by stimulation in the midbrain of man. J. Neurosurg. 1969, 30:14-24.
40. Nashold B.S., Wilson W.P., Slaughter G.S. The midbrain and pain. Advances in Neurology. International Symposium on Pain 1974, 191-196. Raven Press, New York. J.J. Bonica (Ed.).
41. Negishi T., Kawasaki K., Sekiguchi S., Ishii Y., Kyuwa S., Kuroda Y., Yoshikawa Y. Attention-deficit and hyperactive neurobehavioural characteristics induced by hypothyroidism in rats. Behav. Brain Res. 2005, 159:323-331.
42. Nillni E.A., Sevarino K.A. The biology of pro-thyrotropin-releasing hormone-derived peptides. Endocr. Rev. 1999, 20:599-648.
43. Noyes R., Woodman C., Garvey M.J., Cook B.L., Suelzer M., Clancy J., Anderson D.J. Generalized anxiety disorder vs. panic disorder. Distinguishing characteristics and patterns of comorbidity. J. Nerv. Ment. Dis. 1992, 180:369-379.
44. Orenstein H., Peskind A., Raskind M.A. Thyroid disorders in female psychiatric patients with panic disorder or agoraphobia. Am. J. Psychiatry 1988, 145:1428-1430.
45. Parker C.R., Porter J.C. Regional localization and subcellular compartmentalization of thyrotropin-releasing hormone in adult human brain. J. Neurochem. 1983, 41:1614-1622.
46. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego.
47. Placidi G.P., Boldrini M., Patronelli A., Fiore E., Chiovato L., Perugi G., Marazziti D. Prevalence of psychiatric disorders in thyroid diseased patients. Neuropsychobiology 1998, 38:222-225.
48. Prange A.J., Lara P.P., Wilson I.C., Alltop L.B., Breese G.R. Effects of thyrotropin-releasing hormone in depression. Lancet 1972, 2:999-1002.
49. Redei E.E., Solberg L.C., Kluczynski J.M., Paré W.P. Paradoxical hormonal and behavioral responses to hypothyroid and hyperthyroid states in the Wistar-Kyoto rat. Neuropsychopharmacology 2001, 24:632-639.
50. Rondeel J.M., de Greef W.J., van der S.P., Karels B., Klootwijk W., Visser T.J. Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood. Endocrinology 1988, 123:523-527.
51. Rondeel J.M., de Greef W.J., Visser T.J. Effect of thyroid status on release of hypothalamic thyrotropin-releasing hormone. Horm. Metab. Res. Suppl. 1990, 23:1-4.
52. Rondeel J.M., de Greef W.J., Klootwijk W., Visser T.J. Effects of hypothyroidism on hypothalamic release of thyrotropin-releasing hormone in rats. Endocrinology 1992, 130:651-656.
53. Roy-Byrne P.P., Rubinow D.R., Hoban M.C., Grover G.N., Blank D. TSH and prolactin responses to TRH in patients with premenstrual syndrome. Am. J. Psychiatry 1987, 144:480-484.
54. Sait Gönen M., Kisakol G., Cilli A.S., Dikbas O., Gungor K., Inal A., Kaya A. Assessment of anxiety in subclinical thyroid disorders. Endocr. J. 2004, 51:311-315.
55. Sala-Roca J., Marí-Carbonell M.A., Garau A., Darbra S., Balada F. Effects of dysthyroidism in plus maze and social interactions tests. Pharmacol. Biochem. Behav. 2002, 72:643-650.
56. Sandkühler J. Induction of the proto-oncogene c-fos as a cellular marker of brainstem neurons activated from the PAG. The Midbrain Periaqueductal Gray Matter 1991, 267-286. Plenum Press, New York. A. Depaulis, R. Bandler (Eds.).
57. Sandner G., Di Scala G., Rocha B., Angst M.J. C-fos immunoreactivity in the brain following unilateral electrical stimulation of the dorsal periaqueductal gray in freely moving rats. Brain Res. 1992, 573:276-283.
58. Sandner G., Oberling P., Silveira M.C., Di S.G., Rocha B., Bagri A., Depoortere R. What brain structures are active during emotions? Effects of brain stimulation elicited aversion on c-fos immunoreactivity and behavior. Behav. Brain Res. 1993, 58:9-18.
59. Schenberg L.C., Costa M.B., Borges P.C.L., Castro M.F.S. Logistic analysis of the defense reaction induced by eletrical stimulation of the rat mesencephalic tectum. Neurosci. Biobehav. Rev. 1990, 14:473-479.
60. Schenberg L.C., Lovick T.A. Attenuation of the midbrain-evoked defense reaction by selective stimulation of medullary raphe neurons in rats. Am. J. Physiol. 1995, 269:R1378-R1389.
61. Schenberg L.C., Bittencourt A.S., Sudré E.C.M., Vargas L.C. Modeling panic attacks. Neurosci. Biobehav. Rev. 2001, 25:647-659.
62. Schenberg L.C., Póvoa R.M.F., Costa A.L., Caldellas A.V., Tufik S., Bittencourt A.S. Functional specializations within the tectum defense systems of the rat. Neurosci. Biobehav. Rev. 2005, 29:1279-1298.
63. Schenberg L.C., Reis A.M., Póvoa R.M.F., Tufik S., Silva S.R. A panic attack-like unusual stress reaction. Horm. Behav. 2008, 54:584-591.
64. Silveira M.C., Sandner G., Graeff F.G. Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze. Behav. Brain Res. 1993, 56:115-118.
65. Silveira M.C., Graeff F.G., Sandner G. Regional distribution of Fos-like immunoreactivity in the rat brain after exposure to fear-inducing stimuli. Braz. J. Med. Biol. Res. 1994, 27:1077-1081.
66. Silveira M.C., Sandner G., Di Scala G., Graeff F.G. c-Fos immunoreactivity in the brain following electrical or chemical stimulation of the medial hypothalamus of freely moving rats. Brain Res. 1995, 674:265-274.
67. Simon N.M., Blacker D., Korbly N.B., Sharma S.G., Worthington J.J., Otto M.W., Pollack M.H. Hypothyroidism and hiperthyroidism in anxiety disorders revisited: new data and literature review. J. Affect. Dis. 2002, 69:209-217.
68. Siqueira C.C., Rossoni R.R., Schenberg L.C. Dorsal periaqueductal gray matter-evoked panic-like behaviors are markedly inhibited by a low peripheral dose of thyrotropin-releasing hormone. Psychoneuroendocrinology 2009, 10.1016/j.psyneuen.2009.06.021.
69. Stein M.B., Uhde T.W. Thyroid indices in panic disorder. Am. J. Psychiatry 1988, 145:745-747.
70. Stein M.B., Uhde T.W. Endocrine, cardiovascular, and behavioral effects of intravenous protirelin in patients with panic disorder, Arch. Gen. Psychiatry 1991, 48:148-156.
71. Troakes C., Ingram C.D. Anxiety behaviour of the male rat on the elevated plus maze: associated regional increase in c-fos mRNA expression and modulation by early maternal separation. Stress 2008, 12:362-369.
72. Vargas L.C., Schenberg L.C. Long-term effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked innate defensive behaviours of the rat. Psychopharmacology (Berl.) 2001, 155:260-268.
73. Winokur A., Utiger R.D. Thyrotropin-releasing hormone: regional distribution in rat brain. Science 1974, 19(185):265-267.
74. Yang H., Yuan P., Wu V., Tache Y. Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the caudal raphe nuclei in rats. Endocrinology 1999, 140:43-49.
75. Yeragani V.K., Rainey J.M., Pohl R., Ortiz A., Weinberg P., Greshon S. Thyroid hormone levels in panic disorder. Can. J. Psychiatry 1987, 32:467-469.
76. Yuan P.Q., Yang H. Hyperthyroidism decreases thyrotropin-releasing hormone gene expression in the caudal raphe nuclei and the parapyramidal regions in rats. Neurosci. Lett. 1999, 276:189-192.
77. Yuan P.Q., Yang H. Hypothyroidism induces Fos-like immunoreactivity in ventral medullary neurons that synthesize TRH. Am. J. Physiol. 1999, 277:E927-E936.
78. Yuan P.Q., Yang H. Localization of thyroid hormone receptor beta2 in the ventral medullary neurons that synthesize thyrotropin-releasing hormone. Brain Res. 2000, 868:22-30.
79. Zoeller R.T., Wolff R.S., Koller K.J. Thyroid hormone regulation of messenger ribonucleic acid encoding thyrotropin (TSH)-releasing hormone is independent of the pituitary gland and TSH. Mol. Endocrinol. 1988, 2:248-252.